PDL BioPharma surges on spinoff news.

Accentia plummets after the company's sinus drug fails in a trial.

Biotech funds dominate the best-performing list for the week.

Crude oil-related funds rebounded Wednesday.

ETFs that invest in BRICs dominate leaders, while REIT ETFs populate laggard list.

Nelson Peltz and Trian Partners, Wendy's biggest shareholders, are planning to arrange a takeover of the iconic burger chain.

Fed Chairman Jerome Powell has raised his inflation hammer, vowing sharp rate hikes to slow the fastest U.S. inflation in forty years. It won't work.

“Most refinance borrowers continue to remain on the sidelines as a result, and refinance applications have fallen in nine of the past 10 weeks," said the MBA's Joel Kan.

GM says it found 'malicious login activity' on an unspecified number of online user accounts.